Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > legacy shareholder whining
View:
Post by Fuzzybone on Jan 27, 2021 12:20pm

legacy shareholder whining

Fact: the cheetos eating analysts were 200% correct
Fact: you know it all smarter than everybody else, we are the only ones who have a clue shareholders were wrong!!
when this stock when to $14 and you never took any profit, that says a lot about your investing skills
why don't you do all the silent investors on this board a favor and sell or shut UP!!! cause your sniffling and whining is fatiguing. your driving people away.
Comment by jeffm34 on Jan 27, 2021 12:27pm
The only thing people were wrong about was managements ability to run the company successfully. If the same group is trying to take this company forward then they will likely continue making the same mistakes. 
Comment by SPCEO1 on Jan 27, 2021 12:52pm
I would not say that management has done a poor job of running the company. They actually have made a lot of really good decisions in the last couple of years that should have translated into better stock performance. Where they are weak is in selling their story to the market. They just had the best thing that ever happened to the company in its long history - the ability to be a phase III NASH ...more  
Comment by scarlet1967 on Jan 27, 2021 1:07pm
Few years ago I was invested in ZNGA , they came out with Q report which was much better than expected but the stock got beat badly as some analysts downgraded the company cause the tone of the CEO's language was not convincing as crazy as it sounds it seems like the market award companies who have the ability to convince more than the ability to execute!!
Comment by Bucknelly21 on Jan 27, 2021 2:22pm
Almost back under 200m cap, what a joke 
Comment by jeffm34 on Jan 27, 2021 4:24pm
I agree totally when it comes to advancing the science they have done a great job. The executive and board have only one mandate though, that is to maximize shareholder value.  On that front there is no denying they have failed miserably.  I am not confident going forward that is going to change any time soon given the actions of the company.  They need to make changes on the board ...more  
Comment by SPCEO1 on Jan 27, 2021 4:39pm
Shareholders like ourselves have the ability to vote against board members if we are unhappy with their work on our behalf. If enough shareholders feel they have failed us, change at the board level can be achieved. Even after being diluted, if everyone on this board votes to oust the board, it likely would occur. We do not have any ability to directly change management, however, that is the board ...more  
Comment by qwerty22 on Jan 27, 2021 4:50pm
Maybe sacrifice one of them as a warning shot :) Any dead wood? Make space for a more useful board member, maybe US orientated. [/quote]
Comment by palinc2000 on Jan 27, 2021 4:57pm
I would remove the dead wood which would account for 2 BOD members and also at least one new director who was born with a gold  spoon....... [/quote]
Comment by scarlet1967 on Jan 27, 2021 5:03pm
If I recall correctly Spceo suggested in the event they dilute at low SP levels we should all line up and shoot them! They know they have frustrated/humiliated legacy shareholders and so far their justification for that deal is bizarre add to that the radio silence post approval so I am all in to vote against the board and yes they need some less conservative member/members who would appreciate ...more  
Comment by palinc2000 on Jan 27, 2021 6:23pm
THere is only one justification,,,,,,They were not able to get a better deal at this time... Why? Only 2 possible reasons  [/quote]
Comment by qwerty22 on Jan 27, 2021 6:45pm
Dubuc's comfort zone [/quote]
Comment by scarlet1967 on Jan 27, 2021 6:34pm
Intercept today came out with a statement correcting one of their analyst's note which is what THTX should do when their analysts come out with incorrect reports rather than bending over so the can  ... For instance the RBC guy still hasn't acknowledged the patent for Tesamorelin is extended, the concord report was completely wrong. What is the point to have an IR department which ...more  
Comment by scarlet1967 on Jan 27, 2021 12:33pm
Don't worry about being silent after this post you be on my ignore list, thank you for being silent though as your constructive suggestions need to be silenced, as per driving people away what we say here hasn't brought any new investors on the contrary at the times when company should be outspoken their silence drives  investors away.
Comment by qwerty22 on Jan 27, 2021 12:59pm
March 10Th AACR abstracts published, maybe also first patient dosed, my prediction this tiring conversation goes on until then. Enjoy! Btw no need to be offensive just say you're tired of the subject.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities